DEVELOPING PRECISION MEDICINES FOR THE TREATMENT OF CANCER Virtual Investor Event – December 5, 2020 Forward-Looking Statements | --- | --- | |-------|-------| | | | | | | Today's Agenda Topic Speaker | --- | --- | |------------------------------------------------|----------------------------------------------------------------| | | | | Program overview / KO-539 development timeline | Troy Wilson, Ph.D., J.D. President and Chief Executive Officer | | Introduction of KOMET-001 investigators | Stephen Dale, M ...